| Period Ending | Dec 31, 2012 | Dec 31, 2011 |
|---|
|
Total Revenue
|
2,059,037
|
1,675,209
| | Cost of Revenue | 1,817,773 | 1,464,268 | | |
Gross Profit
|
241,264
|
210,941
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
|
Selling General and Administrative | 103,036 | 90,966 |
|
Non Recurring |
-
|
-
|
|
Others | 32,023 | 35,611 |
|
|
|
Total Operating Expenses |
-
|
-
| | | |
Operating Income or Loss
|
106,205
|
84,364
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (71,552) | 1,978 |
|
Earnings Before Interest And Taxes | 34,653 | 86,342 |
|
Interest Expense | 75,610 | 86,480 |
|
Income Before Tax | (40,957) | (138) |
|
Income Tax Expense | 2,486 | 4,088 |
|
Minority Interest |
-
|
-
|
|
|
|
Net Income From Continuing Ops | (115,172) | (4,226) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
|
Extraordinary Items |
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
|
Other Items |
-
|
-
| | | |
Net Income
|
(43,443)
|
(4,226)
| | Preferred Stock And Other Adjustments |
-
|
-
| | |
Net Income Applicable To Common Shares
|
(43,443)
|
(4,226)
|
|